Pharmaceutical preparation comprising DPP-IV inhibitor and other diabetes therapeutic agent in concomitant or combined form

Details for Australian Patent Application No. 2009247251 (hide)

Owner Sanwa Kagaku Kenkyusho Co., Ltd.

Inventors Nakaya, Keizo; Tomoguri, Tetsushi; Fuchigami, Masahiro; Yamashita, Satoko; Ishida, Tsutomu; Goto, Moritaka

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2009247251

PCT Pub. Number WO2009/139362

Priority 2008-127480 14.05.08 JP

Filing date 12 May 2009

Wipo publication date 19 November 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2009/139362 Priority application(s): WO2009/139362

10 February 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Jan 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009247262-Amide compound

2009247250-Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroqui noline derivatives having substituted oxy group